RNTX- Rein Therapeutics, Inc.
Rein Therapeutics, Inc. (RNTX) has 6 insiders with recent SEC Form 4 filings, including 10 buys and 36 sells. RNTX is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 926.4K | $856.9K | - | |
| Dir | 17.5K | $16.2K | - | |
| Dir | 17.5K | $16.2K | - | |
| Dir | 17.5K | $16.2K | - | |
| Dir | 17.5K | $16.2K | - |
Activity
Buys and sells only
Transactions
10 filings
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 14, 2025 | Voss Capital, LP | 10% Owner | Buy | 104,183 | $1.22 | $127,592.92 | +12.7% | -6.4% | - | |
| Oct 28, 2025 | Voss Capital, LP | 10% Owner | Buy | 306,050 | $1.38 | $423,465.64 | +14.8% | +17.4% | - | |
| Dec 5, 2024 | Windsor James Brian45 | President And CEO | Buy | 400 | $2.24 | $897.61 | New | -12.1% | -41.4% | |
| Jun 17, 2024 | University Of Texas/texas Am Investment Management Co87 | 10% Owner | Sell | 6,607 | $3.26 | $21,567.75 | -0.2% | -13.1% | -43.9% | |
| Jun 12, 2024 | University Of Texas/texas Am Investment Management Co87 | 10% Owner | Sell | 24,671 | $3.27 | $80,709.83 | -0.3% | -15.7% | -39.4% | |
| Jun 7, 2024 | University Of Texas/texas Am Investment Management Co87 | 10% Owner | Sell | 12,315 | $3.29 | $40,528.30 | -0.1% | -10.8% | -38.3% | |
| May 1, 2024 | University Of Texas/texas Am Investment Management Co87 | 10% Owner | Sell | 31,151 | $4.47 | $139,102.92 | - | -44.5% | -60.6% | |
| Dec 15, 2023 | Windsor James Brian45 | President And COO | Buy | 225 | $3.37 | $758.25 | New | +45.5% | -40.5% | |
| Nov 20, 2023 | Windsor James Brian45 | President And COO | Buy | 5,076 | $1.97 | $9,987.03 | +11,035% | +149.7% | +49.2% | |
| Jan 8, 2021 | Satter Muneer A58 | See Remarks | Buy | 9,000,000 | $1.10 | $9,900,000.00 | +118.3% | - | - |
Page 1Next →